Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections

NCT06368388 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT06368388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06368388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing Personalized Phage Therapy and Its Comparative Cost in Difficult-to-treat Infections
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2021
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis (diagnosis), hidradenitis suppurativa, musculoskeletal infection, persistent bacteremia, pulmonary infection